Skip to main content

Table 2 Inclusion and exclusion criteria

From: A double-blind, placebo-controlled intervention trial of 3 and 10 mg sublingual melatonin for post-concussion syndrome in youths (PLAYGAME): study protocol for a randomized controlled trial

Inclusion criteria

Exclusion criteria

Age 13-18 years inclusive

Previous significant medical history

Mild traumatic brain injury [139]

Previous concussion within 12 months

Symptomatic (increase in PCS symptoms compared with pre-injury) at 30 days post injury

Lactose intolerance, as the placebo contains lactose

Use of drugs that are likely to affect TMS, fMRI and/or sleep

Inability to complete questionnaires or evaluation

 

Claustrophobia or inability to tolerate MRI

 

Contraindications to TMS (including history of seizures, unexplained loss of consciousness, metal in the head and/or implanted brain medical devices, cardiac pacemaker, and so on)

  1. Post Concussion Syndrome (PCS), Transcranial Magnetic Stimulation (TMS), Magnetic Resonance Imaging (MRI), functional MRI (fMRI).